Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.
about
Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinomaNew findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis.The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
P2860
Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Monoclonal antibodies for the ...... date of an expanding scenario.
@en
type
label
Monoclonal antibodies for the ...... date of an expanding scenario.
@en
prefLabel
Monoclonal antibodies for the ...... date of an expanding scenario.
@en
P2093
P2860
P1476
Monoclonal antibodies for the ...... pdate of an expanding scenario
@en
P2093
Antonio Russo
Francesca Lo Vullo
Francesco Passiglia
Giovanni Sortino
Giuseppe Bronte
Sergio Rizzo
Viviana Bazan
P2860
P356
10.1517/14712598.2015.963052
P407
P577
2014-09-24T00:00:00Z